Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pinar Ataca

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Renal Failure|July 27, 2011
Results of 4-year analysis of conversion from calcineurin inhibitors to mTOR inhibitors in renal transplant patients: single-center experienceMehmet Sert, Ali Celik, Kemal Kural, et al.
International Journal of Hematology|May 4, 2017
Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS)Erden Atilla, Pinar Ataca Atilla, Sinem Civriz Bozdag, et al.
Hematology/Oncology and Stem Cell Therapy|June 21, 2017
Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencePinar Ataca Atilla, Erden Atilla, Sinem Civriz Bozdag, et al.
Antiviral Therapy|February 10, 2018
Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: a retrospective studyErden Atilla, Didem Sahin, Pinar Ataca Atilla, et al.
Blood|October 7, 2024
Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapyDavid G Coffey, Pinar Ataca Atilla, Erden Atilla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2018
CD7 CAR T Cells for the Therapy of Acute Myeloid LeukemiaDiogo Gomes-Silva, Erden Atilla, Pinar Ataca Atilla, et al.
Journal for Immunotherapy of Cancer|September 17, 2020
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemiaPinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, et al.
Nature Biotechnology|July 15, 2020
Engineered off-the-shelf therapeutic T cells resist host immune rejectionFeiyan Mo, Norihiro Watanabe, Mary K McKenna, et al.
Clinical Transplantation|July 27, 2020
Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantationPinar Ataca Atilla, Erman Akkus, Erden Atilla, et al.
Antiviral Therapy|July 5, 2018
Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?Erden Atilla, Merih Yalciner, Pinar Ataca Atilla, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Renal Failure|July 27, 2011
Results of 4-year analysis of conversion from calcineurin inhibitors to mTOR inhibitors in renal transplant patients: single-center experienceMehmet Sert, Ali Celik, Kemal Kural, et al.
International Journal of Hematology|May 4, 2017
Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS)Erden Atilla, Pinar Ataca Atilla, Sinem Civriz Bozdag, et al.
Hematology/Oncology and Stem Cell Therapy|June 21, 2017
Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencePinar Ataca Atilla, Erden Atilla, Sinem Civriz Bozdag, et al.
Antiviral Therapy|February 10, 2018
Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: a retrospective studyErden Atilla, Didem Sahin, Pinar Ataca Atilla, et al.
Blood|October 7, 2024
Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapyDavid G Coffey, Pinar Ataca Atilla, Erden Atilla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2018
CD7 CAR T Cells for the Therapy of Acute Myeloid LeukemiaDiogo Gomes-Silva, Erden Atilla, Pinar Ataca Atilla, et al.
Journal for Immunotherapy of Cancer|September 17, 2020
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemiaPinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, et al.
Nature Biotechnology|July 15, 2020
Engineered off-the-shelf therapeutic T cells resist host immune rejectionFeiyan Mo, Norihiro Watanabe, Mary K McKenna, et al.
Clinical Transplantation|July 27, 2020
Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantationPinar Ataca Atilla, Erman Akkus, Erden Atilla, et al.
Antiviral Therapy|July 5, 2018
Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?Erden Atilla, Merih Yalciner, Pinar Ataca Atilla, et al.
Pageof 3